Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
Identifieur interne : 000891 ( Main/Exploration ); précédent : 000890; suivant : 000892Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
Auteurs : Eric C. Ip ; Shing Fung Lee [Hong Kong]Source :
- Cancer causes & control : CCC [ 1573-7225 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- Wicri :
- geographic : République populaire de Chine, États-Unis.
English descriptors
- KwdEn :
- MESH :
- geographic : China, Europe, United States.
- therapy : Neoplasms.
- Betacoronavirus, Coronavirus Infections, Disease Outbreaks, Health Services Accessibility, Humans, Pandemics, Pneumonia, Viral, Quarantine, Right to Health.
Abstract
The continuing outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 has inflicted considerable burdens onto the health system of China, the world's most populous country. Remarkably, among spectrum of potential mitigation strategies, the Chinese government has implemented all-out lockdowns on large geographical areas, unprecedented in the modern era. This inevitably undermined the right to healthcare of many who now faced great difficulty in getting treatment, especially those with cancer or other life-threatening issues. We elaborate and discuss the medico-legal and human rights consideration triggered by the lockdowns, the unprecedented mass quarantine of Hubei province in China, and the suspension of normal healthcare services. We argue that the same challenge will now be faced by other countries, particularly the USA, Italy, Spain, and France, as the epicentres of COVID-19 has shifted to Europe and the Americas.
DOI: 10.1007/s10552-020-01310-3
PubMed: 32472231
PubMed Central: PMC7259872
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.</title><author><name sortKey="Ip, Eric C" sort="Ip, Eric C" uniqKey="Ip E" first="Eric C" last="Ip">Eric C. Ip</name><affiliation><nlm:affiliation>Centre for Medical Ethics and Law, The University of Hong Kong, Pokfulam Road, Hong Kong Island, Hong Kong SAR.</nlm:affiliation><wicri:noCountry code="subField">Hong Kong SAR</wicri:noCountry></affiliation></author><author><name sortKey="Lee, Shing Fung" sort="Lee, Shing Fung" uniqKey="Lee S" first="Shing Fung" last="Lee">Shing Fung Lee</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, 23 Tsing Chung Koon Road, Tuen Mun, Hong Kong SAR. leesfm@ha.org.hk.</nlm:affiliation><country wicri:rule="url">Hong Kong</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32472231</idno><idno type="pmid">32472231</idno><idno type="doi">10.1007/s10552-020-01310-3</idno><idno type="pmc">PMC7259872</idno><idno type="wicri:Area/Main/Corpus">001045</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001045</idno><idno type="wicri:Area/Main/Curation">001045</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001045</idno><idno type="wicri:Area/Main/Exploration">001045</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.</title><author><name sortKey="Ip, Eric C" sort="Ip, Eric C" uniqKey="Ip E" first="Eric C" last="Ip">Eric C. Ip</name><affiliation><nlm:affiliation>Centre for Medical Ethics and Law, The University of Hong Kong, Pokfulam Road, Hong Kong Island, Hong Kong SAR.</nlm:affiliation><wicri:noCountry code="subField">Hong Kong SAR</wicri:noCountry></affiliation></author><author><name sortKey="Lee, Shing Fung" sort="Lee, Shing Fung" uniqKey="Lee S" first="Shing Fung" last="Lee">Shing Fung Lee</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, 23 Tsing Chung Koon Road, Tuen Mun, Hong Kong SAR. leesfm@ha.org.hk.</nlm:affiliation><country wicri:rule="url">Hong Kong</country></affiliation></author></analytic><series><title level="j">Cancer causes & control : CCC</title><idno type="eISSN">1573-7225</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>China (MeSH)</term><term>Coronavirus Infections (MeSH)</term><term>Disease Outbreaks (MeSH)</term><term>Europe (MeSH)</term><term>Health Services Accessibility (MeSH)</term><term>Humans (MeSH)</term><term>Neoplasms (therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>Quarantine (MeSH)</term><term>Right to Health (MeSH)</term><term>United States (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Chine (MeSH)</term><term>Europe (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term><term>Quarantaine (MeSH)</term><term>Tumeurs (thérapie)</term><term>Épidémies de maladies (MeSH)</term><term>États-Unis (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term><term>Europe</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Coronavirus Infections</term><term>Disease Outbreaks</term><term>Health Services Accessibility</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>Quarantine</term><term>Right to Health</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Betacoronavirus</term><term>Chine</term><term>Europe</term><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Quarantaine</term><term>Épidémies de maladies</term><term>États-Unis</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The continuing outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 has inflicted considerable burdens onto the health system of China, the world's most populous country. Remarkably, among spectrum of potential mitigation strategies, the Chinese government has implemented all-out lockdowns on large geographical areas, unprecedented in the modern era. This inevitably undermined the right to healthcare of many who now faced great difficulty in getting treatment, especially those with cancer or other life-threatening issues. We elaborate and discuss the medico-legal and human rights consideration triggered by the lockdowns, the unprecedented mass quarantine of Hubei province in China, and the suspension of normal healthcare services. We argue that the same challenge will now be faced by other countries, particularly the USA, Italy, Spain, and France, as the epicentres of COVID-19 has shifted to Europe and the Americas.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32472231</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7225</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Cancer causes & control : CCC</Title><ISOAbbreviation>Cancer Causes Control</ISOAbbreviation></Journal><ArticleTitle>Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.</ArticleTitle><Pagination><MedlinePgn>703-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10552-020-01310-3</ELocationID><Abstract><AbstractText>The continuing outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 has inflicted considerable burdens onto the health system of China, the world's most populous country. Remarkably, among spectrum of potential mitigation strategies, the Chinese government has implemented all-out lockdowns on large geographical areas, unprecedented in the modern era. This inevitably undermined the right to healthcare of many who now faced great difficulty in getting treatment, especially those with cancer or other life-threatening issues. We elaborate and discuss the medico-legal and human rights consideration triggered by the lockdowns, the unprecedented mass quarantine of Hubei province in China, and the suspension of normal healthcare services. We argue that the same challenge will now be faced by other countries, particularly the USA, Italy, Spain, and France, as the epicentres of COVID-19 has shifted to Europe and the Americas.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ip</LastName><ForeName>Eric C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Centre for Medical Ethics and Law, The University of Hong Kong, Pokfulam Road, Hong Kong Island, Hong Kong SAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Shing Fung</ForeName><Initials>SF</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4696-9434</Identifier><AffiliationInfo><Affiliation>Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, 23 Tsing Chung Koon Road, Tuen Mun, Hong Kong SAR. leesfm@ha.org.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cancer Causes Control</MedlineTA><NlmUniqueID>9100846</NlmUniqueID><ISSNLinking>0957-5243</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080564" MajorTopicYN="Y">Right to Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cancer incidence</Keyword><Keyword MajorTopicYN="N">Health policy</Keyword><Keyword MajorTopicYN="N">Infectious disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32472231</ArticleId><ArticleId IdType="doi">10.1007/s10552-020-01310-3</ArticleId><ArticleId IdType="pii">10.1007/s10552-020-01310-3</ArticleId><ArticleId IdType="pmc">PMC7259872</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cancer Commun (Lond). 2019 Apr 29;39(1):22</Citation><ArticleIdList><ArticleId IdType="pubmed">31030667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation><ArticleIdList><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Mar;20(3):292-293</Citation><ArticleIdList><ArticleId IdType="pubmed">32078809</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2020 Apr 1;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32236504</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Hong Kong</li></country></list><tree><noCountry><name sortKey="Ip, Eric C" sort="Ip, Eric C" uniqKey="Ip E" first="Eric C" last="Ip">Eric C. Ip</name></noCountry><country name="Hong Kong"><noRegion><name sortKey="Lee, Shing Fung" sort="Lee, Shing Fung" uniqKey="Lee S" first="Shing Fung" last="Lee">Shing Fung Lee</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000891 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000891 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32472231
|texte= Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32472231" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |